Close Menu

Bioarts' chairman Lou Hawthorne talks to the New York Times' Home and Garden section about two dogs that were cloned for him from a border collie-husky mix that died in 2002. The two dogs are not identical to Missy and some of that variation is chalked up to the dogs having mitochondrial DNA from another dog and the egg being implanted in yet another dog. Hawthorne says these clones are the first commercially cloned dogs, however the Korean company RNL Bio has made the same claim.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.